Results 151 to 160 of about 202,290 (315)

Soluble interleukin-6 receptor mediated fatigue highlights immunological heterogeneity of patients with early breast cancer who undergo radiation therapy. [PDF]

Adv Radiat Oncol, 2018
Courtier N, Gambling T, Barrett-Lee P, Mason MD.   +3 more
europepmc   +1 more source

Engineered B7‐H3 Binding in Modular Gp2 Miniproteins

Biotechnology and Bioengineering, EarlyView.
ABSTRACT B7‐H3, an important immune checkpoint modulator of T‐cell function, is a tumor vasculature biomarker and is overexpressed in a variety of cancers. Its expression is associated with tumor growth, metastasis, and poor clinical prognosis, which makes B7‐H3 an appealing target for diagnostics and therapeutics.
Abbigael Harthorn, Hannah K. Windsor, Zachary Schmitz, Nathaniel Cheung, Ebube Agwaramgbo, Benjamin J. Hackel   +5 more
wiley   +1 more source

Clinical research Short period of exercise causes rapid increase of serum interleukin 6 with no effect on its soluble receptor [PDF]

, 2009
Karol Kamiński, Małgorzata Jasiewicz, Małgorzata Knapp, Anna Jackowska, Grażyna Latocha-Korecka, Ewa Waszkiewicz, Włodzimierz J. Musiał   +6 more
openalex  

What Makes an “Ideal” Cell Line for Recombinant Adeno‐Associated Virus Production?

Biotechnology and Bioengineering, EarlyView.
Several host cell types have been used to produce rAAVs to date. Cell line‐specific traits that are beneficial in the context of rAAV manufacturing are reviewed here, with the goal of developing a consensus on the ‘ideal’ characteristics that an rAAV production host should possess (created with Biorender.com).
James Conheady, Nicholas Donohue, Alexandra Bogdanovic, Sharon Davin, Brian Glennon, Niall Barron, C. Mark Smales   +6 more
wiley   +1 more source

Interleukin-6 and soluble interleukin-6 receptor suppress osteoclastic differentiation by inducing PGE2 production in chondrocytes

, 2011
Kazuhiro Honda
openalex   +2 more sources

Soluble interleukin-6 receptors in inflammatory bowel disease: relation to circulating interleukin-6. [PDF]

, 1995
Keiichi Mitsuyama, Atsushi Toyonaga, Ei Sasaki, O. Ishida, Hisami Ikeda, O. Tsuruta, K Harada, H Tateishi, Tsutomu Nishiyama, K Tanikawa   +9 more
openalex   +1 more source

New opportunities for bioscaffold‐enabled spinal cord injury repair

BMEMat, EarlyView.
Schematic illustration of bioscaffolds for spinal cord injury repair. We summarize the effects of bioscaffold properties on SCI repair, highlight different types of bioscaffolds, various fabrication strategies, and in vivo transformations for the clinical development of SCI‐repairing bioscaffolds.
Xiaoqing Qi, Yicheng Fu, Zhaoliang Su, Li Li, Subrata Chakrabarti, Peng Li, Yilun Wu, Fang Liu, Teng Gao, Zhifeng Dong, Lei Liu, Pei Cao   +11 more
wiley   +1 more source

The association between cerebrospinal fluid interleukin-6, soluble interleukin-6 receptor, and interleukin-6 trans-signalling binary complex with postoperative delirium: an observational cohort study. [PDF]

BJA Open
Wu JG, Taylor J, Kunkel D, Maze M, Pearce RA, Sanders RD, Lennertz R.   +6 more
europepmc   +1 more source

Soluble Interleukin-6 Receptor Induces Motor Stereotypies and Co-Localizes with Gp130 in Regions Linked to Cortico-Striato-Thalamo-Cortical Circuits

, 2012
Ankur Patel, Youhua Zhu, Eldo V. Kuzhikandathil, William A. Banks, Allan Siegel, Steven S. Zalcman   +5 more
openalex   +2 more sources

Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55 [PDF]

, 1994
Herbert Tilg, Elizabeth Trehu, MB Atkins, CA Dinarello, J W Mier   +4 more
openalex   +1 more source